CN102284021B - 一种小儿宣肺止咳颗粒组合物及其制备方法和质量检测方法 - Google Patents
一种小儿宣肺止咳颗粒组合物及其制备方法和质量检测方法 Download PDFInfo
- Publication number
- CN102284021B CN102284021B CN201110207281A CN201110207281A CN102284021B CN 102284021 B CN102284021 B CN 102284021B CN 201110207281 A CN201110207281 A CN 201110207281A CN 201110207281 A CN201110207281 A CN 201110207281A CN 102284021 B CN102284021 B CN 102284021B
- Authority
- CN
- China
- Prior art keywords
- solution
- children
- lung
- cough
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010011224 Cough Diseases 0.000 title claims abstract description 109
- 210000004072 lung Anatomy 0.000 title claims abstract description 93
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 239000000203 mixture Substances 0.000 title claims description 10
- 238000003908 quality control method Methods 0.000 title abstract description 5
- 210000000582 semen Anatomy 0.000 claims abstract description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 108
- 239000008187 granular material Substances 0.000 claims description 78
- 238000000034 method Methods 0.000 claims description 51
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 51
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 48
- 238000012360 testing method Methods 0.000 claims description 42
- 239000000463 material Substances 0.000 claims description 30
- 239000013558 reference substance Substances 0.000 claims description 25
- 230000008569 process Effects 0.000 claims description 18
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 16
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 14
- 238000000605 extraction Methods 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 14
- 239000006228 supernatant Substances 0.000 claims description 14
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 12
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 12
- 239000008202 granule composition Substances 0.000 claims description 11
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 claims description 10
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 claims description 10
- 229960003321 baicalin Drugs 0.000 claims description 10
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 claims description 10
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 8
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 8
- 239000011230 binding agent Substances 0.000 claims description 8
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 8
- 239000000284 extract Substances 0.000 claims description 8
- 239000000741 silica gel Substances 0.000 claims description 8
- 229910002027 silica gel Inorganic materials 0.000 claims description 8
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 8
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 239000007921 spray Substances 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 7
- 238000010992 reflux Methods 0.000 claims description 7
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 6
- 239000004375 Dextrin Substances 0.000 claims description 6
- 229920001353 Dextrin Polymers 0.000 claims description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 6
- 229930006000 Sucrose Natural products 0.000 claims description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 6
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 6
- 235000019425 dextrin Nutrition 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 230000002879 macerating effect Effects 0.000 claims description 6
- 238000012856 packing Methods 0.000 claims description 6
- 238000010298 pulverizing process Methods 0.000 claims description 6
- 239000005720 sucrose Substances 0.000 claims description 6
- 238000004809 thin layer chromatography Methods 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- 230000006837 decompression Effects 0.000 claims description 4
- 239000000945 filler Substances 0.000 claims description 4
- 239000000796 flavoring agent Substances 0.000 claims description 4
- 235000019634 flavors Nutrition 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 claims description 4
- 239000003208 petroleum Substances 0.000 claims description 4
- 239000008057 potassium phosphate buffer Substances 0.000 claims description 4
- 238000004064 recycling Methods 0.000 claims description 4
- 239000000377 silicon dioxide Substances 0.000 claims description 4
- 238000011003 system suitability test Methods 0.000 claims description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 3
- 238000001514 detection method Methods 0.000 claims description 3
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 3
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 3
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 2
- SMDOOINVMJSDPS-UHFFFAOYSA-N Astragaloside Natural products C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)OC2C(C(OC3C(C(O)C(O)C(CO)O3)O)C(O)C(CO)O2)O)=C1 SMDOOINVMJSDPS-UHFFFAOYSA-N 0.000 claims description 2
- BALXUFOVQVENIU-GNAZCLTHSA-N Ephedrine hydrochloride Chemical compound Cl.CN[C@@H](C)[C@H](O)C1=CC=CC=C1 BALXUFOVQVENIU-GNAZCLTHSA-N 0.000 claims description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 2
- QMNWISYXSJWHRY-XWJCTJPOSA-N astragaloside Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)C4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)CC3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-XWJCTJPOSA-N 0.000 claims description 2
- TXHIDIHEXDFONW-UHFFFAOYSA-N benzene;propan-2-one Chemical compound CC(C)=O.C1=CC=CC=C1 TXHIDIHEXDFONW-UHFFFAOYSA-N 0.000 claims description 2
- SIHHLZPXQLFPMC-UHFFFAOYSA-N chloroform;methanol;hydrate Chemical compound O.OC.ClC(Cl)Cl SIHHLZPXQLFPMC-UHFFFAOYSA-N 0.000 claims description 2
- 229960002534 ephedrine hydrochloride Drugs 0.000 claims description 2
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 14
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 13
- 208000026435 phlegm Diseases 0.000 abstract description 13
- 241000125142 Seseli Species 0.000 abstract description 8
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract description 7
- 230000003285 pharmacodynamic effect Effects 0.000 abstract description 6
- 208000011580 syndromic disease Diseases 0.000 abstract description 4
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract description 2
- 235000011477 liquorice Nutrition 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 239000002131 composite material Substances 0.000 abstract 4
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 235000008440 Crataegus cuneata Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000014283 Crataegus pinnatifida var major Nutrition 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 241001465251 Ephedra sinica Species 0.000 abstract 1
- 241001252483 Kalimeris Species 0.000 abstract 1
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract 1
- 241000006814 Scutellaria amoena Species 0.000 abstract 1
- 241000220261 Sinapis Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 62
- 229940079593 drug Drugs 0.000 description 47
- 241000699670 Mus sp. Species 0.000 description 46
- 238000002474 experimental method Methods 0.000 description 41
- 239000000243 solution Substances 0.000 description 39
- 230000002496 gastric effect Effects 0.000 description 27
- 238000001802 infusion Methods 0.000 description 27
- 230000037396 body weight Effects 0.000 description 20
- 238000012449 Kunming mouse Methods 0.000 description 15
- 238000005516 engineering process Methods 0.000 description 15
- 241001465754 Metazoa Species 0.000 description 13
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 13
- 241000699666 Mus <mouse, genus> Species 0.000 description 11
- 239000000523 sample Substances 0.000 description 11
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 10
- 230000008961 swelling Effects 0.000 description 10
- 241000700159 Rattus Species 0.000 description 9
- 239000012153 distilled water Substances 0.000 description 9
- 230000003203 everyday effect Effects 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 9
- 230000036760 body temperature Effects 0.000 description 8
- 210000003437 trachea Anatomy 0.000 description 8
- -1 Dichlorodiphenyl Acetate Chemical compound 0.000 description 7
- 239000009636 Huang Qi Substances 0.000 description 7
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 6
- 208000000114 Pain Threshold Diseases 0.000 description 6
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 6
- 230000003110 anti-inflammatory effect Effects 0.000 description 6
- 235000010418 carrageenan Nutrition 0.000 description 6
- 229920001525 carrageenan Polymers 0.000 description 6
- 210000002683 foot Anatomy 0.000 description 6
- 230000037040 pain threshold Effects 0.000 description 6
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 6
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 230000000202 analgesic effect Effects 0.000 description 5
- 230000004856 capillary permeability Effects 0.000 description 5
- 230000029142 excretion Effects 0.000 description 5
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 5
- 239000001685 glycyrrhizic acid Substances 0.000 description 5
- 229960004949 glycyrrhizic acid Drugs 0.000 description 5
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 5
- 235000019410 glycyrrhizin Nutrition 0.000 description 5
- 230000036407 pain Effects 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 239000012488 sample solution Substances 0.000 description 5
- 230000036592 analgesia Effects 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 238000000151 deposition Methods 0.000 description 4
- 230000008021 deposition Effects 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 239000012567 medical material Substances 0.000 description 4
- 239000008096 xylene Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000000679 carrageenan Substances 0.000 description 3
- 229940113118 carrageenan Drugs 0.000 description 3
- 210000005069 ears Anatomy 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 2
- 230000000954 anitussive effect Effects 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 201000009240 nasopharyngitis Diseases 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 240000006409 Acacia auriculiformis Species 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- ILRKKHJEINIICQ-OOFFSTKBSA-N Monoammonium glycyrrhizinate Chemical compound N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ILRKKHJEINIICQ-OOFFSTKBSA-N 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000005141 Otitis Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000000544 articulatio talocruralis Anatomy 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 108010084652 homeobox protein PITX1 Proteins 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000000534 thyroid cartilage Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110207281A CN102284021B (zh) | 2011-07-25 | 2011-07-25 | 一种小儿宣肺止咳颗粒组合物及其制备方法和质量检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110207281A CN102284021B (zh) | 2011-07-25 | 2011-07-25 | 一种小儿宣肺止咳颗粒组合物及其制备方法和质量检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102284021A CN102284021A (zh) | 2011-12-21 |
CN102284021B true CN102284021B (zh) | 2012-07-18 |
Family
ID=45330957
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110207281A Active CN102284021B (zh) | 2011-07-25 | 2011-07-25 | 一种小儿宣肺止咳颗粒组合物及其制备方法和质量检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102284021B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110907550B (zh) * | 2019-11-28 | 2022-04-05 | 健民药业集团股份有限公司 | 一种同时检测小儿宣肺止咳颗粒中六种成分含量的方法 |
CN110940749B (zh) * | 2019-12-10 | 2022-04-05 | 健民药业集团股份有限公司 | 一种同时检测治疗儿童咳嗽的中药四种成分含量的方法 |
CN112649525A (zh) * | 2020-12-01 | 2021-04-13 | 陕西摩美得气血和制药有限公司 | 小儿清热宣肺贴膏中栀子苷和苦杏仁苷的同时测定方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1094629A (zh) * | 1993-05-05 | 1994-11-09 | 王登科 | 小儿益气解毒冲剂及制备方法 |
CN102188591A (zh) * | 2011-05-09 | 2011-09-21 | 武汉健民集团随州药业有限公司 | 一种治疗感冒的中药及其制备方法 |
-
2011
- 2011-07-25 CN CN201110207281A patent/CN102284021B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1094629A (zh) * | 1993-05-05 | 1994-11-09 | 王登科 | 小儿益气解毒冲剂及制备方法 |
CN102188591A (zh) * | 2011-05-09 | 2011-09-21 | 武汉健民集团随州药业有限公司 | 一种治疗感冒的中药及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102284021A (zh) | 2011-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1768854B (zh) | 一种用于溃疡性结肠炎的中药胶囊制剂 | |
CN101396544B (zh) | 宣肺平喘的中药组合物及其制备方法 | |
CN105477166A (zh) | 一种独活寄生汤配方颗粒的制备方法及其质量控制方法 | |
CN101856449B (zh) | 一种清热利湿,活血通淋中药组合物及制备方法和质量检测方法 | |
CN104483417B (zh) | 一种疏风止咳的中药组合物的质量检测方法及其应用 | |
CN102274401B (zh) | 一种治疗胃病的中药制剂及其制备方法和检测方法 | |
CN103412059B (zh) | 一种妇炎康分散片质量控制方法 | |
CN103028065B (zh) | 一种紫香益母制剂及其制备方法和检测方法 | |
CN102284021B (zh) | 一种小儿宣肺止咳颗粒组合物及其制备方法和质量检测方法 | |
CN102305839A (zh) | 宣肺平喘的中药组合物的检测方法 | |
CN102145146B (zh) | 一种治疗泌尿***疾病的药物组合物的检测方法 | |
CN106620610A (zh) | 一种甘草泻心颗粒的制备方法 | |
CN101890087A (zh) | 含有黄连、大黄、黄芩的组合物 | |
CN102920964B (zh) | 一种治疗咳嗽的中药制剂 | |
CN1803179B (zh) | 一种中药组合物及其制备方法和有效成分的检测方法 | |
CN101428130A (zh) | 一种治疗胰腺炎的中药制剂及其制备方法和质量标准 | |
CN100571756C (zh) | 一种治疗感冒的中药组合物及其制备方法和检测方法 | |
CN102288701A (zh) | 宣肺平喘的中药组合物的检测方法 | |
CN103055191B (zh) | 一种治疗肾炎引起血尿的中药的制备方法及质量检测方法 | |
CN101254264A (zh) | 一种治疗痛经的药物组合物及制备方法和质量控制方法 | |
CN101391070A (zh) | 一种具有抗癌作用的中药组合物的质量控制方法 | |
CN104524041A (zh) | 一种灯心止血胶囊及其制备与鉴别方法 | |
CN100515476C (zh) | 复方金蒲胶囊及其制备方法、质量控制方法 | |
CN101224283A (zh) | 治疗糖尿病的中药组合物及其制备方法 | |
CN101385834B (zh) | 一种治疗泌尿***疾病的药物组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20111221 Assignee: Bailu Pharmaceutical Co., Ltd., Shaanxi Assignor: Wang Jianghong Contract record no.: 2012990000642 Denomination of invention: Lung-releasing and cough-relieving grain composition for children and preparation method and quality control method thereof Granted publication date: 20120718 License type: Common License Record date: 20120903 |
|
C56 | Change in the name or address of the patentee | ||
CP02 | Change in the address of a patent holder |
Address after: 712000 new West Ham Shaanxi Metro West Symphony No. 12-2-101 sunmed Greenville Patentee after: Wang Jianghong Address before: 712000 Xianyang city of Shaanxi Province Qin District People's Road No. 16 in the Times Square - type B Building 5 unit 1 floor No. 1 Patentee before: Wang Jianghong |
|
TR01 | Transfer of patent right |
Effective date of registration: 20180102 Address after: 712000 new West Ham Shaanxi Metro West Symphony No. 12-2-101 sunmed Greenville Patentee after: Xianyang Guangtai Pharmaceutical Technology Co. Ltd. Address before: 712000 new West Ham Shaanxi Metro West Symphony No. 12-2-101 sunmed Greenville Patentee before: Wang Jianghong |
|
TR01 | Transfer of patent right | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: Bailu Pharmaceutical Co., Ltd., Shaanxi Assignor: Wang Jianghong Contract record no.: 2012990000642 Date of cancellation: 20181210 |
|
EC01 | Cancellation of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20111221 Assignee: Bailu Pharmaceutical Co., Ltd., Shaanxi Assignor: Xianyang Guangtai Pharmaceutical Technology Co. Ltd. Contract record no.: 2019990000005 Denomination of invention: Lung-releasing and cough-relieving grain composition for children and preparation method and quality control method thereof Granted publication date: 20120718 License type: Common License Record date: 20190108 |
|
EE01 | Entry into force of recordation of patent licensing contract |